“Wells Fargo: These 2 Stocks Could Deliver Triple-Digit Wins”
September 19, 2020
“Bellicum Pharmaceuticals (BLCM)…
Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, BLCM gets a Moderate Buy consensus rating. Based on the $21.50 average price target, which is more aggressive than Birchenough’s, shares could climb 209% higher in the next year…
Global Blood Therapeutics (GBT)…
Are other analysts in agreement? Most are. 13 Buy ratings and 1 Hold have been issued in the last three months. So, the word on the Street is that GBT is a Strong Buy. Given the $113.08 average price target, shares could gain 104% in the next year….”
https://finance.yahoo.com/news/wells-fargo-2-stocks-could-153156987.html